Share ownership Shanghai Shyndec Pharmaceutical Co., Ltd.
Equities
600420
CNE000001JG2
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.28 CNY | +1.82% |
|
+0.82% | +25.43% |
| Dec. 06 | Shyndec Pharma Unit's Codeine Phosphate Included in China's Listing of Chemical Raw Materials | MT |
| Dec. 03 | Shanghai Shyndec Pharmaceutical Gets Drug Registration for Eye Drops | MT |
Share class: Shanghai Shyndec Pharmaceutical Co., Ltd.
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 1,341,172,692 | 559,857,631 ( 41.74 %) | 0 | 41.74 % |
Major shareholders: Shanghai Shyndec Pharmaceutical Co., Ltd.
| Name | Equities | % | Valuation |
|---|---|---|---|
China State-Owned Assets Supervision & Admn Commission
30.83
%
| 413,518,181 | 30.83 % | 703 M ¥ |
China National Accord Medicines Corp. Ltd.
12.46
%
| 167,142,202 | 12.46 % | 284 M ¥ |
Sinopharm Group Co., Ltd.
1.422
%
| 19,068,440 | 1.422 % | 32 M ¥ |
Yan Lin Han
1.292
%
| 17,326,019 | 1.292 % | 29 M ¥ |
Shandong State-Owned Asset Sup. & Adm. Commission
1.181
%
| 15,834,626 | 1.181 % | 27 M ¥ |
China Merchants Fund Management Co., Ltd.
1.046
%
| 14,027,105 | 1.046 % | 24 M ¥ |
Shanghai Guangci Medicine High-Tech Co. Ltd.
0.9335
%
| 12,520,000 | 0.9335 % | 21 M ¥ |
China Southern Asset Management Co., Ltd.
0.7778
%
| 10,431,680 | 0.7778 % | 18 M ¥ |
Monetary Authority of Macao (Investment Management)
0.6911
%
| 9,268,650 | 0.6911 % | 16 M ¥ |
HuaAn Fund Management Co., Ltd.
0.6722
%
| 9,015,287 | 0.6722 % | 15 M ¥ |
| ░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| Name | Equities | % | Valuation |
|---|---|---|---|
China State-Owned Assets Supervision & Admn Commission
100.00
%
| 145,102,781 | 100.00 % | 247 M ¥ |
Breakdown by shareholder type
| Governments | 32.01% |
| China National Accord Medicines Corp. Ltd. | 12.46% |
| Institutional | 7.61% |
| Sinopharm Group Co., Ltd. | 1.42% |
| Individuals | 1.30% |
| Other | 0.93% |
| Unknown | 44.26% |
Based on 1000 largest holdings
Geographical origin of shareholders
| China | 53.45% |
| Individuals | 1.30% |
| Hong Kong | 0.30% |
Based on 1000 largest holdings
Employees
11,608
Sector
Pharmaceuticals
Calendar
2025-03-27
- Q4 2024 Earnings Release (Projected)